KLCI rally picks up speed as promising Covid-19 drug sends markets higher


KUALA LUMPUR: The winning streak on Bursa Malaysia continued for a fourth day as the US announced encouraging early results from a Covid-19 treatment trial.

According to Reuters, Anthony Fauci, the top US infectious disease official, said Gilead's antiviral remdesivir will become the standard of care for the coronavirus after early results seemed to show it helped speed recovery.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

MGRC and Twistcode Technologies collaborate to develop advanced bioinformatics platform
Ringgit trims earlier gains to end slightly lower against US dollar
Ho Hup disposes of Bukit Jalil land for RM110mil
Perodua eyes 79% export surge to 1,960 units this year
Favelle Falco secures RM39.2mil contracts for offshore, tower cranes
RHB Islamic International Asset Management appoints Najman Isa as CEO
Sunzen to buy 70% stake in Eye Nation Medical
KKB gets PETRONAS LPG contract worth RM37.9mil
Bursa Malaysia brings flagship investment fair to Sabah
FBM KLCI continues flirting with 1,600-point level

Others Also Read